- Ibandronic acid 50mg tablets are approved for use in the reduction of bone damage in patients with metastatic breast cancer. Not approved for use in the treatment of patients with other forms of cancer (e.g. prostate).
- Ibandronic acid 150mg tablets are approved for the treatment of osteoporosis in line with NICE
![Green](images/TrafficLightsGreenV2.gif)
- Ibandronic acid 3mg in 3ml injection is approved for use where oral bisphosphonates are not appropriate (not tolerated, contra-indicated because of upper gastro-intestinal problems or insufficiently effective)
![Red](images/TrafficLightsRedV2.gif)
|